unlocked labs

Unlocked Labs is a biotechnology company focused on developing next-generation probiotics designed to target specific biological compounds. Their flagship product, Strain OX164, is a single-strain probiotic that breaks down oxalic acid, a metabolic waste product that can be detrimental to health. This innovative approach contrasts with traditional multi-strain probiotics that offer general gut health support. Unlocked Labs prioritizes scientific rigor and follows industry best practices to ensure the safety and efficacy of their products.

The company is committed to developing a pipeline of single-strain probiotics for various biological compounds, with their current focus on uric acid. They are also open to exploring new targets and welcome suggestions from their customers. Their team of experts, including Dr. Christoph Geisler, founder and CEO, Christina Segal, Head of Marketing Insights, and Dr. Michal Luczak, Head of Detoxification, are passionate about delivering targeted and effective probiotics that improve human health and well-being.

Unlocked Labs is a company focused on developing and delivering single-strain, targeted probiotics designed to address specific health concerns. Their mission is to transform the way we think about microbial supplements by providing highly effective and scientifically-backed probiotics that address specific biological compounds, starting with oxalic acid and uric acid.

Unlocked Labs promotes a culture focused on scientific innovation and a commitment to delivering effective and targeted probiotics. The company's team is passionate about making a difference in people's health and well-being through their groundbreaking work in probiotics. Their website highlights a collaborative and results-oriented environment, emphasizing the importance of rigorous research, third-party validation, and direct communication with customers.